Moderna’s stock jumps after biotech raises sales outlook
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
This is a summary aggregated from MarketWatch. Read the complete article on the original site:
Read full article at MarketWatch
